Long-chain n-3 polyunsaturated fatty acids and triacylglycerol metabolism in the postprandial state

Lipids

Volumn 34, Issue 1, 1999, Pages

  Roche, Helen M ^a   Gibney, Michael J ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; CHYLOMICRON; FISH OIL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

BINDING AFFINITY; CONFERENCE PAPER; DIET RESTRICTION; ENZYME ACTIVITY; HEART PROTECTION; HUMAN; HYDROLYSIS; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; LIPID METABOLISM; MAMMARY GLAND; POSTPRANDIAL STATE;

EID: 0033042381     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02562313     Document Type: Conference Paper

References (68)

1. Roche, H.M., and Gibney, M.J. (1995) Postprandial Triacylglycerolaemia - Nutritional Implications, Prog. Lipid Res. 34, 249-266.
2. Sethi, S., Gibney, M.J., and Williams, C.M. (1993) Postprandial Lipoprotein Metabolism, Nutr Res. Rev. 6, 161-183.
3. Carey, M.C., Small, D.M., and Bliss, C.M. (1983) Lipid Digestion and Absorption, Annu. Rev. Physiol. 45, 651-677.
4. Small, D.M. (1991) The Effects of Glyceride Structure on Absorption and Metabolism, Annu. Rev. Nutr. 11, 413-434.
5. Tso, P., and Balint, J.A. (1986) Formation and Transport of Chylomicrons by Enterocytes to the Lymphatics, Am. J. Physial. 250, G715-G726.
6. Roche, H.M., Zampelas, A., Jackson, K.G., Williams, C.M., and Gibney, M.J. (1998) The Effect of Test Meal MUFA:SFA Ratio on Postprandial Lipid Metabolism, Br. J. Nutr. 79, 419-424.
7. Goldberg, I.J. (1996) Lipoprotein Lipase and Lipolysis: Central Roles in Lipoprotein Metabolism and Atherogenesis, J. Lipid Res. 37, 693-707.
8. Coppack, S.W., Jensen, M.D., and Miles, J.M. (1994) In vivo Regulation of Lipolysis in Humans, J. Lipid Res. 35, 177-193.
9. Schneeman, B.O., Kotite, L., Todd, K.M., and Havel, R.J. (1993) Relationships Between the Responses of Triglyceride-Rich Lipoproteins in Blood Plasma Containing Apolipoproteins B-48 and B-100 to a Fat-Containing Meal in Normolipidemic Humans, Proc. Natl. Acad. Sci. USA 90, 2069-2073.
10. Karpe, F., and Hultin, M. (1995) Endogenous Triglyceride-Rich Lipoproteins Accumulate in Rat Plasma When Competing with a Chylomicron-Like Triglyceride Emulsion for a Common Lipolytic Pathway, J. Lipid Res. 36, 1557-1566.
11. Potts, J.L., Fisher, R.M., Humphreys, S.M., Coppack, S.W., Gibbons, G.F., and Frayn, K.N. (1991) Peripheral Triacylglycerol Extraction in the Fasting and Post-Prandial States, Clin. Sci. 81, 621-626.
12. Berr, F. (1992) Characteriation of Chylomicron Remnant Clearance by Retinyl Palmitate Label in Normal Humans, J. Lipid Rex. 33, 915-930.
13. Frayn, K.M., Wiliams, C.M., and Arner, P. (1996) Are Increased Plasma Nonesterified Fatty Acid Concentrations a Risk Marker for Coronary Heart Disease and Other Chronic Diseases? Clin. Sci. 90, 243-253.
14. NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease (1993) JAMA 269, 505-510.
15. Gotto, A.M. (1998) Triglyceride - The Forgotten Risk Factor, Circulation 97, 1027-1028.
16. Brunzell, J.D., and Austin, M.A. (1989) Plasma Triglyceride Levels and Coronary Disease, N. Engl. J. Med. 320, 1273-1275.
17. Schwandt, P. (1990) The Triglyceride Controversy: A Review of the Data, Eur. Heart J. 11, 38-43.
18. Criqui, M.H., Heiss, G., Cohn, R., Cowan, L.D., Suchindran, C.M., Bangdiwala, S., Kritchevsky, S., Jacobs, D.R., O'Grady, H.K., and Davis, C.E. (1993) Plasma Ttriglyceride Level and Mortality from Coronary Heart Disease, N. Engl. J. Med. 328, 1220-1225.
19. Castelli, W.P. (1986) The Triglyceride Issue: A View from Framingham, Am. Heart J. 112, 432-437.
20. Bainton, D., Miller, N.E., Bolton, C.H., Yarnell, J.W.G., Sweetnam, P.M., Baker, I.A., Lewis, B., and Elwood, P.C. (1992) Plasma Triglyceride and High Density Lipoprotein Cholesterol as Predictors of Ischaemic Heart Disease in British Men. The Cearphilly and Speedwell Collaborative Heart Disease Studies, Br. Heart J. 68, 60-66.
21. Hokanson, J.E., and Austin, M.A. (1996) Plasma Triglyceride Level is a Risk Factor for Cardiovascular Disease Independent of High-Density Lipoprotein Cholesterol Level: A Meta Analysis of Populaion Based Prospective Studies, J. Cardiovasc. Risk 3, 213-219.
22. Stampfer, M.J., Krauss, R.M., Ma, J., Blanche, P.L., Holl, L.G., Sacks, F.M., and Hennekens, C.H. (1996) A Prospective Study of Triglyceride Level, Low-Density Lipoprotein Particle Diameter, and Risk of Myocardial Infarction, JAMA 276, 882-888.
23. Groot, P.H.E., van Stiphout, W.A.H.J., Krauss, X.H., Jansen, H., van Tol, A., van Ramshorst, E., Chin-On, S., Hofman, A., Cresswell, S.R., and Havekes, L. (1991) Postprandial Lipoprotein Metabolism in Normolipidemic Men With and Without Coronary Artery Disease, Arterioscler. Thromb. 11, 653-662.
24. Patsch, J.R., Miesenbock, G., Hopferwieser, T., Muhlberger, V., Knapp, E., Dunn, J.K., Gotto, A.M., and Patsch, W. (1993) Relation of Triglyceride Metabolism and Coronary Artery Disease, Arterioscler. Thromb. 12, 1336-1345.
25. Karpe, F., Steiner, G., Uffelman, K., Olivecrona, T., and Hamsten, A. (1994) Postprandial Lipoproteins and Progression of Coronary Atherosclerosis, Atherosclerosis 106, 83-97.
26. Shaikh, M., Wootton, R., Nordestgaard, B.G., Baskerville, P., Lumley, J.S., La Ville, A.E., Quiney, J., and Lewis, B. (1991) Quantitative Studies of Transfer in vivo of Low Density, Sf 12-60, and Sf 60-400 Lipoproteins Between Plasma and Arterial Intima in Humans, Arterioscler. Thromb. II, 569-577.
27. Zilversmit, D.B. (1979) Atherogenesis: A Postprandial Phenomenon, Circulation 60, 473-485.
28. Cohn, J.S. (1994) Postprandial Lipid Metabolism, Current Opinion Lipidology 5, 185-190.
29. Karpe, F., Tornvall, P., Olivecrona, T. Steiner, G., Carlson, L.A., and Hamsten, A. (1993) Composition of Human Low Density Lipoprotein: Effects of Postprandial Triglyceride-Rich Lipoproteins, Lipoprotein Lipase, Hepatic Lipase and Cholesteryl Ester Transfer Protein, Atherosclerosis 98, 33-49.
30. Griffin, B.A., Freeman, D.J., Tait, G.W., Thompson, J., Caslake, M.J., Packard, C.J., and Shepherd, J. (1994) Role of Plasma Triglyceride in the Regulation of Plasma Low Density Lipoprotein (LDL) Subfractions: Relative Contribution of Small, Dense LDL to Coronary Heart Disease Risk, Atherosclerosis 106, 241-253.
31. 2. Relationship of the Plasma Levels of This Lipoprotein Species to Its Composition, to the Magnitude of Postprandial Lipemia, and to the Activities of Lipoprotein Lipase and Hepatic Lipase, J. Clin. Invest. 80, 341-347.
32. Patsch, J.R., Karlin, J.B., Scott, L.W., Smith, L.C., and Gotto, A.M. (1983) Inverse Relationship Between Blood Levels of High Density Lipoprotein Subfraction 2 and Magnitude of Post-prandial Lipaemia, Proc. Natl. Acad. Sci. USA 80, 1449-1453.
33. 3 by Hepatic Lipase, J. Clin. Invest. 74, 2017-2023.
34. Roche, H.M., and Gibney, M.J. (1997) Postprandial Coagulation Factor VII Activity: The Effect of Monounsaturated Fatty Acids, Br. J. Nutr. 77, 537-549.
35. Reaven, G.M. (1997) Do High Carbohydrate Diets Prevent the Development or Attenuate the Manifestations (or both) of Syndrome X? A Viewpoint Strongly Against, Current Opinion Lipidology 8, 23-27.
36. Austin, M.A., King, M.C., Vranizan, K.M., and Krauss, R.M. (1990) Atherogenic Lipoprotein Phenotype. A Proposed Genetic Marker of Coronary Heart Disease Risk, Circulation 82, 495-506.
37. Bang, H.O., and Dyerberg, J. (1972) Plasma Lipids and Lipoproteins in Greenlandic West-Coast Eskimos, Acta Med. Scand. 192, 85-94.
38. Hirai, A., Hamazaki, T., Terano, T., Hirai, A., Hamazaki, T., Terano, T., Nishikawa, T., Tamura, Y., and Kumagai, A. (1980) Eicosapentaenoic Acid and Platelet Function in Japanese, Lancet, 1132-1133.
39. Burr, M.L., Fehily, A.M., Gilbert, J.F., Rogers, S., Holliday, R.M., Sweetnam, P.M., Elwood, P.C., and Deadman, N.M. (1989) Effects of Changes in Fat, Fish, and Fibre Intakes on Death and Myocardial Reinfarction: Diet and Reinfarction Trial (DART), Lancet 2, 757-761.
40. Leaf, A., and Weber, P.C. (1988) Cardiovascular Effects of n-3 Fatty Acids, N. Engl. J. Med. 318, 549-557.
41. Schmidt, E.B., and Dyerberg, J. (1994) Omega-3 Fatty Acids. Current Status in Cardiovascular Medicine, Drugs 47, 405-424.
42. Simopoulos, A.P. (1991) Omega-3 Fatty Acids in Health and Disease and in Growth and Development, Am. J. Clin. Nutr. 54, 438-463.
43. Harris, W.S. (1997) n-3 Fatty Acids and Serum Lipoproteins: Human Studies, Am. J. Clin. Nutr. 65 (Suppl.), 1645S-1654S.
44. Knapp, H.G. (1997) Dietary Fatty Acids in Human Thrombosis and Hemostasis, Am. J. Clin. Nutr. 65 (Suppl.), 1687S-1698S.
45. Harris, W.S. (1996) n-3 Fatty Acids and Lipoproteins: Comparison of Results from Human and Animal Studies, Lipids 31, 243-252.
46. Sanders, T.A.B., and Roshanai, F. (1983) The Influence of Different Types of ω-3 Polyunsaturated Fatty Acids on Blood Lipids and Platelet Function in Healthy Volunteers, Clin. Sci. 64, 9-99.
47. Blonk, M.C., Bilo, H.J.G., Nauta, J.J.P., Popp-Snijders, C., Mulder, C., and Donker, A.J.M. (1990) Dose-Response Effects of Fish-Oil Supplementation in Healthy Volunteers, Am. J. Clin. Nutr. 52, 120-127.
48. Schmidt, E.B., Varming, K., Ernst, E., Madsen, P., and Dyerberg, J. (1990) Dose-Response Studies on the Effect of n-3 Polyunsaturated Fatty Acids on Lipids and Haemostasis, Thromb. Haemost. 63, 1-5.
49. Roche, H.M., and Gibney, M.J. (1996) Postprandial Triacylglycerolaemia: The Effect of Low-Fat Dietary Treatment With and Without Fish Oil Supplementation, Eur. J. Clin. Nutr. 50, 617-624.
50. Schmidt, E.B., Lervang, H.-H., Varming, K., Madsen, P., and Dyerberg, J. (1992) Long-Term Supplementation with n-3 Fatty Acids, I: Effect on Blood Lipids, Haemostasis and Blood Pressure, Scand. J. Clin. Lab. Invest. 52, 221-228.
51. Saynor, R., and Gillott, T. (1992) Changes in Blood Lipids and Fibrinogen with a Note on Safety in a Long-Term Study on the Effects of n-3 Fatty Acids in Subjects Receiving Fish Oil Supplements and Followed for Seven Years, Lipids 27, 533-538.
52. Harris, W.S., Connor, W.E., Alam, N., and Illingworth, R.D. (1988) Reduction of Postprandial Triglyceridemia in Humans by Dietary n-3 Fatty Acids, J. Lipid Res. 29, 1451-1460.
53. Weintraub, M.S., Zechner, R., Brown, A., Eisenberg, S., and Breslow, J.L. (1988) Dietary Polyunsaturated Fats of the ω-6 and ω-3 Series Reduce Postprandial Lipoprotein Levels, J. Clin. Invest. 82, 1884-1893.
54. Williams, C.M., Moore, F., Morgan, L., and Wright, J. (1992) Effects of n-3 Fatty Acids on Postprandial Triacylglycerol and Hormone Concentrations in Normal Subjects, Br. J. Nutr. 68, 655-666.
55. Agren, J.J., Hanninen, O., Julkunen, A., Fogelholm, L., Vidgren, H., Schwab, U., Pynnonen, O., and Uusitupa, M. (1996) Fish Diet, Fish Oil and Docosahexaenoic Acid Rich Oil Lower Fasting and Postprandial Plasma Lipid Levels, Eur. J. Clin. Nutr. 50, 765-771.
56. Childs, M.T., King, I.B., and Knopp, R.H. (1990) Divergent Lipoprotein Responses to Fish Oils with Various Ratios of Eicosapentaenoic Acid and Docosahexaenoic Acid, Am. J. Clin. Nutr. 52, 632-639.
57. Rambjor, G.S., Walen, A.I., Windsor, S.L., and Harris, W.S. (1996) Eicosapentaenoic Acid Is Primarily Responsible for Hypotriglyceridemic Effect of Fish Oil in Humans, Lipids 31, S45-S49.
58. Froyland, L., Madsen, L., Vaagenes, H., Totland, G.K., Auwerx, J., Kryvi, H., Staels, B., and Berge, R.K. (1997) Mitochondrion Is the Principal Target for Nutritional and Pharmacological Control of Triglyceride Metabolism, J. Lipid Res. 38, 1851-1858.
59. Zampelas, A., Murphy, M., Morgan, L.M., and Williams, C.M. (1994) Postprandial Lipoprotein Lipase, Insulin and Gastric Inhibitory Polypeptide Responses to Test Meals of Different Fatty Acid Composition: Comparison of Saturated, n-6 and n-3 Polyunsaturated Fatty Acids, Eur. J. Clin. Nutr. 48, 849-858.
60. Harris, W.S., Hustvedt, B.E., Hagen, E., Green, M.H., Lu, G., and Drevon, C.A. (1997) n-3 Fatty Acids and Chylomicron Metabolism in the Rat, J. Lipid Res. 38, 503-515.
61. Rustan, A.C., Nossen, J.O., Christiansen, E.N., and Drevon, C.A. (1988) Eicosapentaenoic Acid Reduces Hepatic Synthesis and Secretion of Triacylglycerol by Decreasing the Activity of Acyl-Coenzyme A:1,2-Diacylglycerol Acyltransferase, J. Lipid Res. 29, 1417-1426.
62. Rustan, A.C., and Drevon, C.A. (1989) Eicosapentaenoic Acid Inhibits Hepatic Production of Very Low Density Lipoproteins, J. Int. Med. 225, 31-38.
63. Wong, S., and Nestel, P.J. (1987) Eicosapentaenoic Acid Inhibits the Secretion of Triacylglycerol and of Apoprotein B and the Binding of LDL in Hep G2 Cells, Atherosclerosis 64, 139-146.
64. Harris, W.S., Connor, W.E., Illingworth, R.D., Rothrock, D.W., and Foster, D.M. (1990) Effects of Fish Oil on VLDL Triglyceride Kinetics in Humans, J. Lipid Res. 31, 1549-1558.
65. Brunzell, J.D., and Austin, M.A. (1989) Plasma Triglyceride Levels and Coronary Disease, N. Engl. J. Med. 320, 1273-1275.
66. Kasim-Karis, S.E., Herrmann, R., and Almario, R. (1995) Effects of Omega-3 Fatty Acids on Intravascular Lipolysis of Very-Low-Density Lipoproteins in Humans, Metabolism 44, 1223-1230.
67. Harris, W.S., Lu, G., Rambjor, G.S., Walen, A.I., Ontko, J.A., Cheng, Q., and Windsor, S.L. (1997) Influence of n-3 Fatty Acid Supplementation on the Endogenous Activities of Plasma Lipases, Am. J. Clin. Nutr. 66, 254-260.
68. Murphy, M.C., Zampelas, A., Puddicombe, S.M., Furlonger, N.P., Morgan, L.M., and Williams, C.M. (1993) Pre-translational Regulation of the Expression of Lipoprotien Lipase Gene by Dietary Fatty Acids in the Rat, Br. J. Nutr. 70, 727-736.